Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
Senate Bill 3250
116th Congress(2019-2020)
DHS Opioid Detection Resilience Act of 2020
Introduced
Introduced
Introduced in Senate on Feb 4, 2020
Overview
Text
Introduced in Senate 
Feb 4, 2020
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in Senate(Feb 4, 2020)
Feb 4, 2020
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
S. 3250 (Introduced-in-Senate)


116th CONGRESS
2d Session
S. 3250


To ensure U.S. Customs and Border Protection officers, agents, and other personnel have adequate synthetic opioid detection equipment, that the Department of Homeland Security has a process to update synthetic opioid detection capability, and for other purposes.

IN THE SENATE OF THE UNITED STATES

February 4, 2020

Mr. Cornyn (for himself and Ms. Rosen) introduced the following bill; which was read twice and referred to the Committee on Homeland Security and Governmental Affairs

A BILL

To ensure U.S. Customs and Border Protection officers, agents, and other personnel have adequate synthetic opioid detection equipment, that the Department of Homeland Security has a process to update synthetic opioid detection capability, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “DHS Opioid Detection Resilience Act of 2020”.

SEC. 2. Strategy to ensure detection of all opioid purity levels at ports of entry.

Not later than 180 days after the date of the enactment of this Act, the Commissioner of U.S. Customs and Border Protection (referred to in this section as “CBP”) shall—

(1) implement a strategy to ensure deployed chemical screening devices are able to identify in an operational environment narcotics at purity levels less than or equal to 10 percent, or provide directors of ports of entry with an alternate method for identifying narcotics at lower purity levels; and

(2) require testing of any new chemical screening devices to understand the abilities and limitations of such devices relating to identifying narcotics at various purity levels before CBP commits to the acquisition of such devices.

SEC. 3. Plan to ensure opioid detection equipment resiliency.

(a) In general.—Not later than 180 days after the date of the enactment of this Act, the Secretary of Homeland Security shall implement a plan for the long-term development of a centralized spectral database for chemical screening devices.

(b) Requirements.—The plan required under subsection (a) shall address the following:

(1) How newly identified spectra will be collected, stored, and distributed to such devices in their operational environment, including at ports of entry.

(2) Identification of parties responsible for updates and maintenance of the centralized spectral database.